| Is the Combination of Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratios a Useful Predictor of Treatment Response and Prognosis in Patients with Non-Small Cell Lung Cancer? |
|
Tanoglu, Alpaslan
(Department of Gastroenterology, GATA Haydarpasa Training Hospital)
Yiyit, Nurettin (Department of Thoracic Surgery, GATA Haydarpasa Training Hospital) Berber, Ufuk (Department of Pathology, GATA Haydarpasa Training Hospital) Karagoz, Ergenekon (Department of Infectious Diseases and Clinical Microbiology, GATA Haydarpasa Training Hospital) |
| 1 | Stotz M, Gerger A, Eisner F, et al (2013). Increased neutrophillymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer, 109, 416-21. DOI ScienceOn |
| 2 | Tanoglu A, Karagoz E, Yiyit N, Berber U (2014). Is combination of neutrophil to lymphocyte ratio and platelet lymphocyte ratio a useful predictor of postoperative survival in patients with esophageal squamous cell carcinoma? Onco Targets Ther, 7, 433-4. |
| 3 | Unal D1, Eroglu C, Kurtul N, Oguz A, Tasdemir A. (2013). Are neutrophil/lymphocyte and platelet/lymphocyte rates in patients with non small cell lung cancer associated with treatment response and prognosis? Asian Pac J Cancer Prev, 14, 5237-42. 과학기술학회마을 DOI ScienceOn |
| 4 | Wang D, Yang JX, Cao DY, et al (2013). Preoperative neutrophillymphocyte and platelet-lymphocyte ratios as independent predictors of cervical stromal involvement in surgically treated endometrioid adenocarcinoma. OncoTargets Ther, 6, 211-6 |
| 5 | Zheng YB, Zhao W, Liu B, et al (2013). The blood neutrophil-tolymphocyte ratio predicts survival in patients with advanced hepatocellular carcinoma receiving sorafenib. Asian Pac J Cancer Prev, 14, 5527-31. 과학기술학회마을 DOI ScienceOn |
| 6 | Smith RA, Ghaneh P, Sutton R, et al (2008).Prognosis of resected ampullary adenocarcinoma by preoperative serum CA19-9 levels and platelet-lymphocyte ratio. J Gastrointest Surg, 12, 1422-8. DOI ScienceOn |
| 7 | Tanoglu A, Karagoz E (2014). Predictive role of neutrophil to lymphocyte ratio in patients with advanced hepatocelluler carcinoma receiving sorafenib. Asian Pac J Cancer Prev, 15, 1063. DOI ScienceOn |
 |
Korea Institute of Science and Technology Information
Gwahangno, Yuseong-gu, Daejeon, 305-806, Korea TEL : +82-42-869-1752
Copyright (c) 2009 KISTI. All Rights Reserved. For more information mail to
webmaster
